Encysive Holds Hope For Thelin Despite Receiving Second “Approvable” Letter

Company says it does not anticipate having to collect additional data on the pulmonary arterial hypertension drug.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet